ESX1 is an X-linked homeobox gene encoding a transcription factor with dual roles in spermatogenesis and placental development. Functionally, ESX1 inhibits polyubiquitinated cyclin A and cyclin B1 degradation, arresting the cell cycle at early M phase during male germ cell division 1. The N-terminal region acts as a transcriptional repressor binding to specific DNA sequences (5'-TAATGTTATTA-3'), including within the KRAS gene promoter, while the C-terminal region regulates cyclin stability 1. ESX1 expression serves as a robust molecular marker for residual spermatogenesis; its detection in testicular tissue correlates strongly with successful sperm recovery in azoospermic patients, with lower promoter methylation associated with expression 2. Clinically, mutations in ESX1 are associated with non-obstructive azoospermia (NOA) in multiple populations; specific variants like the compound mutation p.[P365R; L366V] impair cyclin stabilization, compromising M phase arrest and contributing to male infertility 34. ESX1 activation in germ cells regulates networks of genes involved in cell proliferation and differentiation, with altered expression patterns observed in azoospermic patients carrying ESX1 mutations 4. Additionally, ESX1 shows evidence of positive selection in primate evolution, particularly in the C-terminal region, suggesting reproductive significance 1.